Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 123

1.

Adipokine Pattern After Bariatric Surgery: Beyond the Weight Loss.

Adami GF, Scopinaro N, Cordera R.

Obes Surg. 2016 Aug 29. [Epub ahead of print] Review.

PMID:
27573513
2.

The economic burden of severe hypoglycemia: Two sides of the same coin. Comment on G. Veronese and Coll. Costs associated with emergency care and hospitalization for severe hypoglycemia.

Gallo F, Maggi D, Cordera R.

Nutr Metab Cardiovasc Dis. 2016 Sep;26(9):850-1. doi: 10.1016/j.numecd.2016.04.003. Epub 2016 Apr 20. No abstract available.

PMID:
27212618
3.

Serum Leptin and Adiponectin Concentration in Type 2 Diabetes Patients in the Short and Long Term Following Biliopancreatic Diversion.

Adami GF, Gradaschi R, Andraghetti G, Scopinaro N, Cordera R.

Obes Surg. 2016 Oct;26(10):2442-8. doi: 10.1007/s11695-016-2126-z.

PMID:
26989058
4.

Long-term clinical and functional impact of biliopancreatic diversion on type 2 diabetes in morbidly and non-morbidly obese patients.

Scopinaro N, Camerini G, Papadia F, Andraghetti G, Cordera R, Adami GF.

Surg Obes Relat Dis. 2016 May;12(4):822-7. doi: 10.1016/j.soard.2015.12.011. Epub 2015 Dec 10.

PMID:
26947789
5.

From bariatric to metabolic surgery: Looking for a "disease modifier" surgery for type 2 diabetes.

Cordera R, Adami GF.

World J Diabetes. 2016 Jan 25;7(2):27-33. doi: 10.4239/wjd.v7.i2.27. Review.

7.

HOMA, BMI, and Serum Leptin Levels Variations during Antiviral Treatment Suggest Virus-Related Insulin Resistance in Noncirrhotic, Nonobese, and Nondiabetic Chronic Hepatitis C Genotype 1 Patients.

Grasso A, Malfatti F, Andraghetti G, Marenco S, Mazzucchelli C, Labanca S, Cordera R, Testa R, Picciotto A.

Gastroenterol Res Pract. 2015;2015:975695. doi: 10.1155/2015/975695. Epub 2015 Mar 3.

8.

IGF1 regulates PKM2 function through Akt phosphorylation.

Salani B, Ravera S, Amaro A, Salis A, Passalacqua M, Millo E, Damonte G, Marini C, Pfeffer U, Sambuceti G, Cordera R, Maggi D.

Cell Cycle. 2015;14(10):1559-67. doi: 10.1080/15384101.2015.1026490.

9.

Impaired increase of plasma abscisic Acid in response to oral glucose load in type 2 diabetes and in gestational diabetes.

Ameri P, Bruzzone S, Mannino E, Sociali G, Andraghetti G, Salis A, Ponta ML, Briatore L, Adami GF, Ferraiolo A, Venturini PL, Maggi D, Cordera R, Murialdo G, Zocchi E.

PLoS One. 2015 Feb 27;10(2):e0115992. doi: 10.1371/journal.pone.0115992. eCollection 2015.

10.

Continuous subcutaneous insulin infusion in Italy: third national survey.

Bruttomesso D, Laviola L, Lepore G, Bonfanti R, Bozzetto L, Corsi A, Di Blasi V, Girelli A, Grassi G, Iafusco D, Rabbone I, Schiaffini R; Italian Study Group on Diffusion of CSII.

Diabetes Technol Ther. 2015 Feb;17(2):96-104. doi: 10.1089/dia.2014.0242. Epub 2014 Dec 5.

PMID:
25479035
11.

Metformin, cancer and glucose metabolism.

Salani B, Del Rio A, Marini C, Sambuceti G, Cordera R, Maggi D.

Endocr Relat Cancer. 2014;21(6):R461-71. doi: 10.1530/ERC-14-0284. Epub 2014 Oct 1. Review.

12.

High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7).

Zampetti S, Campagna G, Tiberti C, Songini M, Arpi ML, De Simone G, Cossu E, Cocco L, Osborn J, Bosi E, Giorgino F, Spoletini M, Buzzetti R; NIRAD Study Group.

Eur J Endocrinol. 2014 Dec;171(6):697-704. doi: 10.1530/EJE-14-0342. Epub 2014 Sep 11.

13.

Effects of gastric bypass on type 2 diabetes in patients with BMI 30 to 35.

Scopinaro N, Adami GF, Papadia FS, Camerini G, Carlini F, Briatore L, Andraghetti G, Catalano M, Cordera R.

Obes Surg. 2014 Jul;24(7):1036-43. doi: 10.1007/s11695-014-1206-1.

PMID:
24647849
14.

Appetite control and gastrointestinal hormonal behavior (CCK, GLP-1, PYY 1-36) following low doses of a whey protein-rich nutraceutic.

Sukkar SG, Vaccaro A, Ravera GB, Borrini C, Gradaschi R, Massa Sacchi-Nemours A, Cordera R, Andraghetti G.

Med J Nutrition Metab. 2013;6:259-266. Epub 2013 Feb 5.

15.

Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer.

Marini C, Salani B, Massollo M, Amaro A, Esposito AI, Orengo AM, Capitanio S, Emionite L, Riondato M, Bottoni G, Massara C, Boccardo S, Fabbi M, Campi C, Ravera S, Angelini G, Morbelli S, Cilli M, Cordera R, Truini M, Maggi D, Pfeffer U, Sambuceti G.

Cell Cycle. 2013 Nov 15;12(22):3490-9. doi: 10.4161/cc.26461.

16.

Metformin impairs glucose consumption and survival in Calu-1 cells by direct inhibition of hexokinase-II.

Salani B, Marini C, Rio AD, Ravera S, Massollo M, Orengo AM, Amaro A, Passalacqua M, Maffioli S, Pfeffer U, Cordera R, Maggi D, Sambuceti G.

Sci Rep. 2013;3:2070. doi: 10.1038/srep02070.

17.

Comments on ORIGIN trial.

Mazzucchelli C, Bordone C, Maggi D, Cordera R.

Nutr Metab Cardiovasc Dis. 2013 Aug;23(8):e33-4. doi: 10.1016/j.numecd.2013.03.002. Epub 2013 Jun 17. No abstract available.

PMID:
23786822
18.

Pioglitazone Randomised Italian Study on Metabolic Syndrome (PRISMA): effect of pioglitazone with metformin on HDL-C levels in Type 2 diabetic patients.

Genovese S, Passaro A, Brunetti P, Comaschi M, Cucinotta D; PRISMA study group, Egan CG, Chinea B, Bravi F, Di Pietro C.

J Endocrinol Invest. 2013 Sep;36(8):606-16. doi: 10.3275/8895. Epub 2013 Mar 19.

PMID:
23511244
19.

Tissue specificity in fasting glucose utilization in slightly obese diabetic patients submitted to bariatric surgery.

Morbelli S, Marini C, Adami GF, Kudomi N, Camerini G, Iozzo P, Massollo M, Capitanio S, Bodrato S, Verardi MT, Papadia F, Cordera R, Knuuti J, Scopinaro N, Sambuceti G.

Obesity (Silver Spring). 2013 Mar;21(3):E175-81. doi: 10.1002/oby.20003.

20.

Caveolin-1 and polymerase I and transcript release factor: new players in insulin-like growth factor-I receptor signaling.

Hamoudane M, Maffioli S, Cordera R, Maggi D, Salani B.

J Endocrinol Invest. 2013 Mar;36(3):204-8. doi: 10.3275/8848. Epub 2013 Feb 12. Review.

PMID:
23404184
Items per page

Supplemental Content

Loading ...
Write to the Help Desk